Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study
European Journal of Neurology2021Vol. 28(9), pp. 2846–2854
Citations Over TimeTop 10% of 2021 papers
Fabien Hauw, Guillaume Fargeot, David Adams, Shahram Attarian, Cécile Cauquil, Jean‐Baptiste Chanson, Alain Créange, Thierry Gendre, Kumaran Deiva, Émilien Delmont, Bruno Francou, Steeve Genestet, Thierry Küntzer, Philippe Latour, Gwendal Le Masson, Laurent Magy, Clotilde Nardin, François Ochsner, Guilhem Solé, Tanya Stojkovic, Thierry Maisonobe, Céline Tard, Peter Van Den Berghe, Andoni Echaniz‐Laguna
Abstract
In this study, 35 of 1104 (3.2%) patients initially diagnosed with CIDP had CMT. Importantly, the cost of treating these 35 misdiagnosed patients was significantly higher than the cost of performing CMT genetic analysis in 1104 patients (4.6 M€ vs. 2.7 M€), suggesting that CMT genetic investigations should be more widely used before diagnosing CIDP.
Related Papers
- → Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis(2019)17 cited
- → Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients(2003)68 cited
- → Treatment of chronic inflammatory demyelinating polyneuropathy(2003)2 cited
- → Treatment of Inflammatory Demyelinating Polyneuropathy(1999)
- → Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)(2023)